Qualitests diabetes insulin syringe recalled

Qualitest Pharmaceuticals and the FDA notified patients and healthcare professionals of a voluntary nationwide recall of two lots of Accusure diabetes insulin syringes because they have been found to have needles which can detach from the syringe.

When the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into the syringe, or remain in the skin after an injection. Physicians are advised to tell consumers who have any recalled Accusure insulin syringes (31 G –Short Needle-either 1/2 cc or 1 cc, lot number 6JCB1 or lot number 7CPT1) to stop using them and contact Qualitest at 1-800-444-4011 for product replacement instructions, according to the agency and Huntsville, Ala.-based company.

The recalled products were distributed from January 2007 through June 2008 to wholesalers and retail pharmacies across the U.S., including Puerto Rico.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.